Listen Score
LS 49
Global Rank
TOP 0.5%

ABOUT THIS PODCAST 🔗

Hosts:
Update frequency:
weekly
Average audio length:
31 minutes
English
United States
427 episodes
since March 2, 2018
episodic

AUDIENCE OF THIS PODCAST 🔗

~76.37% of listeners are from United States.
🇺🇸
US
76.37%
🇮🇪
IE
6.61%
🇦🇺
AU
3.74%
🇬🇧
GB
3.29%
🇩🇪
DE
1.67%
🇮🇳
IN
1.54%
🇨🇦
CA
1.24%
🇯🇵
JP
0.95%
🇪🇸
ES
0.53%
🇮🇹
IT
0.37%
🇱🇹
LT
0.29%
🇨🇿
CZ
0.26%
🇸🇬
SG
0.26%
🇫🇷
FR
0.23%
🇭🇷
HR
0.23%
🇹🇷
TR
0.21%
🇰🇷
KR
0.13%
🇳🇴
NO
0.13%
🇮🇱
IL
0.13%
🇨🇭
CH
0.10%
🇲🇽
MX
0.10%
🇳🇱
NL
0.10%
🇧🇪
BE
0.10%
🇿🇦
ZA
0.10%
Others
1.32%
* Data source: directly measured on Listen Notes. real-time

LATEST EPISODE 🔗

On this week’s episode of "The Readout LOUD": the failure of two closely followed heart disease drugs and how these setbacks may impact the future of cardiovascular drug research. Plus, drug safety concerns weigh on some of the biggest companies in the sector.  For years, it was widely believ…

SEARCH PAST EPISODES

Search past episodes of The Readout Loud.

PREVIOUS EPISODES

How will the midterm results affect drug pricing policy? What is the fate of the Food and Drug Administration? And why are women traveling to fertility clinics abroad? On this week's episode of “The Readout LOUD,” STAT's biotech podcast, we bring on our Washington correspondent Daniel Payne to ch…
What is Adam doing in Spain? How did doctors react to detailed data on Merck and Moderna's mRNA cancer vaccine? And what are the next big advances in oncology? On this week's episode of “The Readout LOUD,” STAT's biotech podcast, we bring on our colleague Andrew Joseph to discuss the latest cancer…
Helen Branswell was a renowned infectious disease reporter who earned the respect and admiration of experts and public health officials with her authoritative, prescient reporting on the flu, polio, Ebola and the Covid-19 pandemic. This week’s episode of “The Readout LOUD” is dedicated to Helen, w…
Longevity medicine is now estimated to be a multitrillion dollar industry. But what are people paying for, and does it work? On this week's episode of “The Readout LOUD,” STAT's biotech podcast, we bring on STAT reporter Sarah Todd to discuss the booming industry of longevity health and her visit …
How has the National Institutes of Health been spending its budget? Why are biotech investors feeling gloomy? And what is the most quintessential Boston movie? We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. We bring on STAT reporter Anil Oza and …
On this week’s episode of "The Readout LOUD": Why have so many Americans lost trust in science? And how have our policy leaders fueled that mistrust? We speak to STAT’s new trust-in-science reporter Nicholas Florko about the impact of Americans’ growing skepticism of science.  Your co-ho…
"The Readout LOUD" is going international this week. STAT's Jason Mast joins the podcast from Shanghai, where he's digging into what the rise of Chinese drug development means for the biotech industry. The hosts also speak to colleague Margaret Manto about Heidi Overton, the president's pick to be…
International researchers got a reprieve in the courts this week. But many are still considering leaving the states for opportunities elsewhere. What does that mean for the future of American medical research? We discuss that, plus the latest news in the life sciences, on this week's episode of "T…
On this week’s episode of “The Readout LOUD”: The pharma industry invested billions of dollars to develop drugs heralded as the next era in the treatment of heart disease — but why did they fail? And what does this mean for the development of new heart medicines moving forward? Cardiologist and bi…
Disclaimer: The podcast and artwork embedded on this page are from STAT, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.